Cargando…
FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease
BACKGROUND: Intestinal failure-associated liver disease (IFALD) is a clinical challenge. The pathophysiol-ogy is multifactorial and remains poorly understood. Disturbed recirculation of bile salts, e.g. due to loss of bile via an enterocutaneous fistula, is considered a major contributing factor. We...
Autores principales: | Koelfat, Kiran V.K., Visschers, Ruben G.J., Hodin, Caroline M.J.M., de Waart, D. Rudi, van Gemert, Wim G., Cleutjens, Jack P.M., Gijbels, Marion J., Shiri-Sverdlov, Ronit, Mookerjee, Rajeshwar P., Lenaerts, Kaatje, Schaap, Frank G., Steven W.M., Olde Damink |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426251/ https://www.ncbi.nlm.nih.gov/pubmed/30895273 |
Ejemplares similares
-
FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis
por: van Golen, Rowan F., et al.
Publicado: (2018) -
Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid
por: de Haan, Lianne R., et al.
Publicado: (2021) -
Bile Salt and FGF19 Signaling in the Early Phase of Human Liver Regeneration
por: Koelfat, Kiran V.K., et al.
Publicado: (2021) -
SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
por: Cui, Shuang, et al.
Publicado: (2023) -
The role of bile salts in liver regeneration
por: van de Laarschot, Liyanne F. M., et al.
Publicado: (2016)